Last update:

Attention deficit disorders news

Psychology & Psychiatry

First double-blind controlled trial of TNS shows reduced symptoms in some children with ADHD with minimal risk

Currently approved in Canada and Europe for adults with medication-resistant depression and seizures, trigeminal nerve stimulation (TNS) has been found to be an effective and safe means of treatment for children with attention ...

Attention deficit disorders

Dasotraline promising for the treatment of ADHD in children

(HealthDay)—Treatment with dasotraline (4 mg/day) significantly improves attention-deficit/hyperactivity disorder (ADHD) symptoms in children aged 6 to 12 years, according to a study published online March 7 in the Journal ...

Psychology & Psychiatry

A gene involved in ADHD could be related to addictive substance use

Some variations in the gene LPHN3, associated with attention deficit/hyperactivity disorder (ADHD) in children and adults, could favour the likelihood to smoke, consume alcohol, cannabis and other addictive substances, according ...

Attention deficit disorders

ADHD diagnoses poorly documented

Many ADHD diagnoses are not well documented, according to a review of the medicals records of 549 children with an ADHD diagnosis.

Psychology & Psychiatry

Genetic risk for ADHD manifests in brain structure in childhood

There is only scant scientific evidence available on whether the genetic risk for developing specific psychiatric disorders or cognitive traits is manifest in brain structure from childhood, and to date, studies have focused ...

Obstetrics & gynaecology

Prenatal valproate exposure linked to increased ADHD risk

(HealthDay)—Use of the antiepileptic drug (AED) valproate during pregnancy is associated with an increased risk for attention-deficit/hyperactivity disorder (ADHD) among offspring, according to a study published online ...